Editor's note: Although cancer has been recognized as a malignant disease for centuries, it has only been in the last few decades that the first molecular abnormalities underlying specific tumors have ...
Chronic myeloid leukemia (CML) is a type of cancer that affects blood-forming tissues. With appropriate treatment, it is possible for people with CML to experience remission. In the 1970s, the 5-year ...
This publication is sponsored by Takeda Pharmaceuticals U.S.A., Inc. This clinical brief provides key information on third-generation tyrosine kinase inhibitor for patients with chronic phase chronic ...
A study from a major cancer center collected data on 2857 patients with Ph+ CML, most of whom were White and middle-aged. Ten-year overall survival for patients with Ph+ CML treated since 2000 was ...
Effect of race and comorbidities on patterns of bevacizumab toxicity: A single-institution experience. Correlation of 5-year survival and cure in NSCLC: An analysis of delayed cancer deaths in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback